CD34 and myeloproliferative disorder: According to different technical approaches, as presented in Table 4 (we prepared amplified RNA from peripheral blood of individual MPN patients and controls rather than performing pools of RNA from patient groups and bone marrow derived CD34+ cells), we found some minor overlap in differentially expressed genes.